PMR and GCA Part 1: Background, presentation and diagnosis

Update: 2021-10-08

Description

What you need to know for your boards on Polymyalgia Rheumatica and Giant Cell Arteritis: A little epidemiology and pathophysiology, with a particular focus on the clinical presentation and workup (including imaging).

Comments

In Channel

Treatment of Axial Spondyloarthritis (including Ankylosing Spondylitis)

2025-06-2601:08:04

Ankylosing Spondylitis (Axial Spondyloarthritis) Part 1: Everything other than treatment.

2024-12-1701:13:43

Uveitis

2024-06-2701:13:40

Still’s Disease

2023-11-0901:09:14

Scleroderma Part 2: Management

2023-04-2659:20

Scleroderma Part 1: Clinical Presentation And Workup

2023-04-1901:06:30

Gout Part 2: Treatment

2023-03-0701:11:16

Gout Part 1: Background, Presentation and Diagnosis

2023-02-2745:42

Antiphospholipid Syndrome

2022-12-1401:18:42

Rheumatoid Arthritis Management: Part 2

2022-11-0801:24:45

Rheumatoid Arthritis Management: Part 1

2022-10-2701:19:17

PMR and GCA Part 2: Management

2021-10-0844:07

PMR and GCA Part 1: Background, presentation and diagnosis

2021-10-0856:30

Psoriatic Arthritis

2021-06-2401:17:07

Lupus Nephritis

2021-04-1401:13:19

ANCA Vasculitis

2021-03-0401:09:56

IgG4-Related Disease

2020-11-2549:11

Myositis

2020-09-0857:47

Osteoporosis

2020-07-2201:11:01

00:00

PMR and GCA Part 1: Background, presentation and diagnosis

#box-pro-ellipsis-176577265075987{-webkit-line-clamp:2;}PMR and GCA Part 1: Background, presentation and diagnosis

PMR and GCA Part 1: Background, presentation and diagnosis

Dr. Karim Ladak

PMR and GCA Part 1: Background, presentation and diagnosis